Viewing Eye Care Network

Latest News



Arshad Khanani, MD, MA, FASRS, discussed the real-world implications of SOL-1 data for AXPAXLI in wet AMD
0:41
AXPAXLI's real-world potential to reduce wet AMD treatment gaps
43 minutes ago
Sandeep Dev, MD, FASRS, on AI's future role in retina care
0:24
AI's future role in retina care recordkeeping, imaging, and research
4 hours ago
Why every eye doctor should check dry eye first
1:16
Why every eye doctor should check dry eye first
4 hours ago
Which baseline characteristics predict vision loss in geographic atrophy?
0:21
Which baseline characteristics predict vision loss in geographic atrophy?
5 hours ago
Treatment durability and Medicare status both drive retinal outcomes
0:38
Treatment durability and Medicare status both drive retinal outcomes
a day ago
Arshad Khanani, MD, MA, FASRS, discussed positive data from the SOL-1 phase 3 trial of Axpaxli (OTX-TKI)
1:00
AXPAXLI shows superiority in SOL-1 wet AMD trial
a day ago
Ensuring cataract patients are happy
0:36
Redefining surgical success as "20/happy"
2 days ago
Sundeep Dev, MD, FASRS on faricimab timing and durability
0:24
Early faricimab use linked to longer treatment durability
3 days ago
Margaret Chang, MD: AI in retinal imaging
1:02
Margaret Chang, MD: AI in retinal imaging
3 days ago
Patient education in the AI era
0:47
Patient education in the AI era
4 days ago

Digital Edition


Podcasts


Continuing Medical Education


All News

From a phase 3 durability readout for a first-in-class TKI to a new interchangeable ranibizumab biosimilar and a deep dive into geographic atrophy management, June brought a wide-ranging mix of regulatory, clinical, and practice-pattern news for retina specialists